Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Biotech
Roche stops pivotal TIGIT trial as Keytruda lands knockout blow
Keytruda beat Roche’s TIGIT candidate at an interim analysis, prompting the drugmaker to stop the study and consider changes to the broader program.
Nick Paul Taylor
Jul 4, 2024 5:10am
Annovis glosses over primary goal in pivotal Parkinson’s data
Jul 2, 2024 9:38am
Cartesian claims autoimmune CAR-T win after changing endpoint
Jul 2, 2024 7:56am
J&J posts pivotal data, prepares to crash argenx, UCB's party
Jul 1, 2024 6:00am
GeNeuro's long COVID trial fails, triggering layoffs
Jun 28, 2024 5:34am
Silence breaks down phase 1 data on blood disorder prospect
Jun 27, 2024 9:40am